EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rspo3-mediated metabolic liver zonation regulates systemic glucose metabolism and body mass in mice

Kenji Uno iD, Takuya Uchino, Takashi Suzuki, Yohei Sayama, Naoki Edo, Kiyoko Uno-Eder, Koji Morita, Toshio Ishikawa, Miho Koizumi, Hiroaki Honda, Hideki Katagiri, Kazuhisa Tsukamoto

PLOS Biology · 24.01.2025 · 23 (1) · e3002955

DOI: 10.1371/journal.pbio.3002955 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Biology, online erschienen am 24.01.2025. Verfasst von Kenji Uno und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Liver, Thrombospondins, Glucose. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Culture, Sports, Science and Technology of Japan, Mochida Memorial Foundation for Medical and Pharmaceutical Research, Daiwa Securities Health Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The unique architecture of the liver consists of hepatic lobules, dividing the hepatic features of metabolism into 2 distinct zones, namely the pericentral and periportal zones, the spatial characteristics of which are broadly defined as metabolic zonation. R-spondin3 (Rspo3), a bioactive protein promoting the Wnt signaling pathway, regulates metabolic features especially around hepatic central veins. However, the functional impact of hepatic metabolic zonation, regulated by the Rspo3/Wnt signaling pathway, on whole-body metabolism homeostasis remains poorly understood. In this study, we analyze the local functions of Rspo3 in the liver and the remote actions of hepatic Rspo3 on other organs of the body by using murine models. Rspo3 expression analysis shows that Rspo3 expression patterns are spatiotemporally controlled in the murine liver such that it locates in the pericentral zones and converges after feeding, and the dynamics of these processes are disturbed in obesity. We find that viral-mediated induction of Rspo3 in hepatic tissue of obesity improves insulin resistance and prevents body weight gain by restoring attenuated organ insulin sensitivities, reducing adipose tissue enlargement and reversing overstimulated adaptive thermogenesis. Denervation of the hepatic vagus suppresses these remote effects, derived from hepatic Rspo3 induction, toward adipose tissues and skeletal muscle, suggesting that signals are transduced via the neuronal communication consisting of afferent vagal and efferent sympathetic nerves. Furthermore, the non-neuronal inter-organ communication up-regulating muscle lipid utilization is partially responsible for the ameliorations of both fatty liver development and reduced skeletal muscle quality in obesity. In contrast, hepatic Rspo3 suppression through Cre-LoxP-mediated recombination system exacerbates diabetes due to glucose intolerance and insulin resistance, promotes fatty liver development and decreases skeletal muscle quality, resulting in obesity. Taken together, our study results reveal that modulation of hepatic Rspo3 contributes to maintaining systemic glucose metabolism and body composition via a newly identified inter-organ communication mechanism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LiverThrombospondinsGlucoseAnimalsMiceObesityInsulin ResistanceMaleMice, Inbred C57BLWnt Signaling PathwayAdipose TissueBody WeightThermogenesis

Substanzen

ThrombospondinsR-spondin3 protein, mouseGlucose

Autor:innen und Institutionen

  • Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan.
  • Teikyo Academic Research Center, Tokyo, Japan.
  • Field of Human Disease Models, Tokyo Women's Medical University, Tokyo, Japan.
  • Department of Metabolism and Diabetes, Tohoku University Graduate School of Medicine, Sendai, Japan.

ORCID-Profile: Kenji Uno

Förderung

  • Ministry of Education, Culture, Sports, Science and Technology of Japan
  • Mochida Memorial Foundation for Medical and Pharmaceutical Research
  • Daiwa Securities Health Foundation
  • TERUMO LIFE SCIENCE FOUNDATION
  • Takeda Science Foundation
  • Koyanagi Foundation

Zitieren

APA

Uno, K., Uchino, T., Suzuki, T., Sayama, Y., Edo, N., Uno-Eder, K., Morita, K., Ishikawa, T., Koizumi, M., Honda, H., Katagiri, H., & Tsukamoto, K. (2025). Rspo3-mediated metabolic liver zonation regulates systemic glucose metabolism and body mass in mice. PLOS Biology, 23(1), e3002955. https://doi.org/10.1371/journal.pbio.3002955

Vancouver

Uno K, Uchino T, Suzuki T, Sayama Y, Edo N, Uno-Eder K, et al. Rspo3-mediated metabolic liver zonation regulates systemic glucose metabolism and body mass in mice. PLOS Biology. 2025;23(1):e3002955. doi:10.1371/journal.pbio.3002955

BibTeX
@article{Uno2025,
  author = {Uno, Kenji and Uchino, Takuya and Suzuki, Takashi and Sayama, Yohei and Edo, Naoki and Uno-Eder, Kiyoko and Morita, Koji and Ishikawa, Toshio and Koizumi, Miho and Honda, Hiroaki and Katagiri, Hideki and Tsukamoto, Kazuhisa},
  title = {Rspo3-mediated metabolic liver zonation regulates systemic glucose metabolism and body mass in mice},
  journal = {PLOS Biology},
  year = {2025},
  volume = {23},
  number = {1},
  pages = {e3002955},
  doi = {10.1371/journal.pbio.3002955}
}
Kostenlos starten →